Succinate-binding polypeptides and use thereof
AssigneeB.G. Negev Technologies and Applications Ltd., At Ben-Gurion University
InventorEhud OHANA
Life of this patent
Estimating the term…
Loading patent…
AssigneeB.G. Negev Technologies and Applications Ltd., At Ben-Gurion University
InventorEhud OHANA
Estimating the term…
Polypeptides comprising an amino acid sequence of Slc26a6 or IRBIT comprising a mutation that increases NaDC-1 binding, stability of the polypeptide, stability of NaDC-1 complex or a combination thereof are provided. Polypeptides comprising an amino acid sequence of a mutant succinate receptor 1 (mutSUCNR1), comprising a mutation that increases succinate binding, stability of the polypeptide, stability of the mutSUCNR1-succinate complex or combinations thereof are also provided. Compositions comprising the polypeptides, nucleic acid molecules and vectors encoding the polypeptides, and methods of use of the polypeptides or compositions, specifically for treating succinate-associate diseases and conditions are also provided.
A method of treating or preventing a succinate-associated disease or condition in a subject in need thereof, the method comprising decreasing serum succinate levels in said subject, thereby treating or preventing a succinate-associated disease or condition.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A polypeptide comprising
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of increasing succinate reabsorption from urine in a subject in need thereof, the method comprising at least one of:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.